Neumora Therapeutics Inc. Common Stock
NMRA | NASDAQ
$0.74
+$0.05 (+6.97%)
Sep 22, 2026, 10:57 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -212.75M | -222.39M | -236.93M | -236.3M | -252.09M | -258.06M | -243.79M | -293.7M | -274.18M | -254.02M | -235.93M | -155.34M | -131.66M | -123.49M | -130.9M | -129.73M | -278.41M | -265.05M | -237.31M | -230.34M | -52.31M | -35.3M |
Depreciation & Amortization | 47K | 59K | 208K | 356K | 489K | 630K | 631K | 640K | 657K | 668K | 668K | 649K | 622K | 605K | 594K | 578K | 582K | 553K | 538K | 470K | 320K | 195K |
Stock-Based Compensation | 27.98M | 27.96M | 29.88M | 32.37M | 36.34M | 41.94M | 39.99M | 36.14M | 32.64M | 22.42M | 17.24M | 13.98M | 9.63M | 8.84M | 8.3M | 6.72M | 5.81M | 5.12M | 4.27M | 3.88M | 2.69M | 1.63M |
Other Working Capital | -28.55M | -4.68M | -508K | 654K | 20.48M | 19.06M | 19.76M | 7.02M | -18.89M | -12.2M | -8.32M | 814K | 2.27M | 4.66M | -5.7M | -7.25M | -4.71M | -3.3M | -202K | 2.69M | 205K | -1.67M |
Other Non-Cash Items | 29.25M | 1.66M | 841K | -254K | -362K | -2.46M | -2.41M | 62M | 62.3M | 63.36M | 63.64M | -527K | 428K | 875K | 14.06M | 14.8M | 171.19M | 171.11M | 158.04M | 161.94M | 4.76M | 4.69M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 220K | 220K | 220K |
Change in Working Capital | -25.04M | -677K | -437K | -5M | 19.95M | 18.52M | 22.64M | 10.88M | -19.75M | -5.62M | -8.9M | -964K | 784K | -2.58M | -6.95M | -6.25M | -4.55M | -4.09M | -961K | 1.25M | -1M | -3.19M |
Operating Cash Flow | -180.52M | -193.4M | -206.44M | -208.83M | -195.68M | -199.43M | -182.94M | -184.04M | -198.33M | -173.19M | -163.28M | -142.2M | -120.19M | -115.75M | -114.9M | -113.88M | -105.38M | -92.36M | -75.42M | -62.58M | -45.32M | -31.76M |
Capital Expenditures | n/a | n/a | n/a | -16K | n/a | n/a | n/a | -44K | -81K | -81K | -117K | -96K | -189K | -371K | -511K | -676K | -763K | -720K | -817K | -1.93M | -1.71M | -1.57M |
Cash Acquisitions | 158K | 242K | 171K | 171K | 84K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -137K | -39.52M | -83.9M | -190.66M | -190.65M | -170.8M | -312.22M | -225.4M | -238.27M | -253.39M | -109.07M | -137.1M | -136.72M | -195.42M | -226.37M | -178.27M | -165.79M | -72.43M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 93.83M | 162.63M | 251.17M | 216.69M | 322.41M | 294.41M | 242.44M | 272.72M | 152.46M | 170.41M | 178.17M | 179.87M | 172.46M | 113.73M | 69.39M | 29.3M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 184K | 1.08M | 1.08M | 896K | 896K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.48M | -10.52M | -10.52M | -10.85M | -13.3M | n/a | 990K | 1.32M | 1.29M |
Investing Cash Flow | 94.03M | 124.43M | 168.52M | 27.08M | 132.75M | 123.6M | -70.56M | 41.92M | -91.25M | -88.43M | 64.39M | 42.68M | 35.56M | -79.59M | -168.01M | -160.17M | -177.41M | -86.45M | -817K | -939K | -392K | -283K |
Debt Repayment | 38.76M | 57.16M | 57.16M | 18.26M | 18.4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 19.21M | 19.65M | 19.65M | 1.88M | 1.65M | 1.65M | 1.65M | -225K | 232.02M | 232.32M | 232.42M | 234.28M | 89.43M | 91.22M | 90.77M | 88.62M | 293.42M | 291.98M | 292.61M | 292.91M | 920K | 280K |
Financial Cash Flow | 78.8M | 87.96M | 77.09M | 33.89M | 35.56M | 19.76M | 21.6M | 5.55M | 236.04M | 233.68M | 231.94M | 259.25M | 114.4M | 116.2M | 115.74M | 88.55M | 293.36M | 291.92M | 293.51M | 305.67M | 13.68M | 13.04M |
Net Cash Flow | -7.69M | 19M | 39.17M | -147.86M | -27.37M | -56.07M | -231.89M | -136.57M | -53.54M | -27.94M | 133.05M | 159.73M | 29.77M | -79.15M | -167.17M | -185.5M | 10.57M | 113.1M | 217.27M | 242.15M | -32.03M | -19M |
Free Cash Flow | -180.52M | -193.4M | -206.44M | -208.84M | -195.68M | -199.43M | -182.94M | -184.08M | -198.41M | -173.27M | -163.4M | -142.3M | -120.38M | -116.12M | -115.41M | -114.56M | -106.14M | -93.08M | -76.24M | -64.51M | -47.04M | -33.33M |
Adj. Free Cash Flow | -208.5M | -221.35M | -236.32M | -241.21M | -232.01M | -241.37M | -222.93M | -220.22M | -231.05M | -195.69M | -180.64M | -156.28M | -130.01M | -124.96M | -123.71M | -121.28M | -111.95M | -98.2M | -80.51M | -68.39M | -49.73M | -34.96M |
Maintenance CapEx | -25K | -25K | -25K | -16K | n/a | n/a | n/a | -44K | -81K | -81K | -117K | -96K | -189K | -343K | -454K | -562K | -582K | -553K | -538K | -470K | n/a | n/a |
Growth CapEx | 25K | 25K | 25K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -28K | -57K | -114K | -181K | -167K | -279K | -1.46M | n/a | n/a |
Owner Earnings | -180.55M | -193.42M | -206.47M | -208.84M | -195.68M | -199.43M | -182.94M | -184.08M | -198.41M | -173.27M | -163.4M | -142.3M | -120.38M | -116.09M | -115.35M | -114.44M | -105.96M | -92.92M | -75.96M | -63.05M | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove NMRA